Vivanza Biosciences: Outcome Of The Board Meeting And Submission Of Un-Audited Financial Results For The Quarter And Nine Months Ended 31ST December 2025

Pursuant to Regulation 30 and Regulation 33 of SEBI (LODR) Regulations 2015 this is to inform you that the Board of Directors at its meeting held on Thursday 12th February 2026 has inter alia considered and approved the following:1. The Un-audited Financial results Standalone and Consolidated as per indian accounting Standards (IND AS) along with the Limited review Report (s) issued by the Statutory Auditor for the Quarter and Nine Months ended 31st December 2025.The meeting of the Board of Directors of the Company commenced ot 2:30 P.M. and concluded at 3:00 P.M